Human papilloma virus DNA revelation in the superficial urothelial bladder carcinoma
https://doi.org/10.17650/1726-9776-2008-4-1-34-35
Abstract
An immunohistochemical research with antibodies to the mutant p53 protein and a revelation of the human papilloma virus DNA 16 and 18 types via in situ hybridization at the histological sections of the urothelial carcinoma are realized. The material of 44 patients with the superficial bladder cancer (Ta and T1 stages) and with a presence of the indirect signs of the viral infection was studied. 16 patients were included in the group of high risk recurrence, 13 patients were included in the group of the mean risk, 15 patients were included in the group of the low risk. HPV DNA was revealed in 12 of 44 cases only in patients of the mean and high risk groups (5 and 7 cases, respectively); all the positive results in the high risk group were with the HPV 16 type probe. Evaluation of the p53 protein showed a significant increase of its expression in the mean and high risk groups. p53 protein expression mean value was 23,67% in the low risk group, 36,53% in the mean risk group, 53,43% in the high risk group. Presence of HPV DNA was associated with the high p53 expression in the vast majority of cases.
About the Authors
U. U. Andreeva
Moscow oncology research institute named after P.A. Gercen
Russian Federation
125284, Moscow
Russian Federation
125284, Moscow
L. E. Zavalishina
Moscow oncology research institute named after P.A. Gercen
Russian Federation
125284, Moscow
Russian Federation
125284, Moscow
A. A. Morozov
Moscow oncology research institute named after P.A. Gercen
Russian Federation
125284, Moscow
Russian Federation
125284, Moscow
I. G. Rusakov
Moscow oncology research institute named after P.A. Gercen
Russian Federation
125284, Moscow
Russian Federation
125284, Moscow
G. A. Frank
Moscow oncology research institute named after P.A. Gercen
Russian Federation
125284, Moscow
Russian Federation
125284, Moscow
References
1. Cecchini S., Cipparone I., Confortini M. Uretral cytology of cytobrush specimens. Acta Cytol 1998;32:314—7.
2. Lopez-Beltran A., Escudero A.L. Human papillomavirus and bladder cancer. Biomed Pharmacother 1997;57:252—7.
3. Park T.W., Fujiwara H., Wright T.C. Molecular biology of cervical cancer and its precursors. Cancer 1995;76:1902—13.
4. Savelieva E., Belair CD., Newton M.A. et al. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human uroepithelial cells. Oncogene 1997;14:551—60.
5. Киселев Ф.Л. Вирус-ассоциированные опухоли человека: рак шейки матки и вирусы папиллом. Биохимия 2000;65(1):79—91.
6. Мяндина Г.И., Пягай П.Э., Иткес А.В. и др. Детекция генома вируса папилломы человека типа 16 в клетках опухолей периферической крови пациентов, страдающих раком мочевого пузыря. Вестн РУДН. Серия Медицина; 2003;5(24):29—32.
7. Frank G., Zavalishina L., Andreeva Yu. Immunohisnochemical study of urothelial carcinoma in patients with different tumor progression risk. Mod Pathol 2006;19(Suppl 3):115.
8. Guo C.C., Fine S.W., Epstein J.I. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 2006;30(7):883—91.
9. European Association of Urology. Pocket guidelines. 2006 ed. p. 5—20.
10. Завалишина Л.Э., Андреева Ю.Ю., Маныкин А.А., Франк Г.А. Выявление вируса папилломы человека при опухолях эпителиальной природы. Пособие для врачей. М., МНИОИ им. П.А. Герцена; 2004.
Review
For citations:
Andreeva U.U., Zavalishina L.E., Morozov A.A., Rusakov I.G., Frank G.A. Human papilloma virus DNA revelation in the superficial urothelial bladder carcinoma. Cancer Urology. 2008;4(1):34-35. (In Russ.) https://doi.org/10.17650/1726-9776-2008-4-1-34-35
Views:
293
Email this article 